These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31788067)

  • 1. JMJD3 promotes the epithelial-mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis.
    Zou S; Zhang D; Xu Z; Wen X; Zhang Y
    Oncol Lett; 2019 Dec; 18(6):5930-5940. PubMed ID: 31788067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
    Lin Y; Ma Q; Li L; Wang H
    Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of TGF-β-induced EMT by JMJD3/KDM6B histone H3K27 demethylase.
    Lee SH; Kim O; Kim HJ; Hwangbo C; Lee JH
    Oncogenesis; 2021 Feb; 10(2):17. PubMed ID: 33637682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.
    Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D
    Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.
    Aversa I; Zolea F; Ieranò C; Bulotta S; Trotta AM; Faniello MC; De Marco C; Malanga D; Biamonte F; Viglietto G; Cuda G; Scala S; Costanzo F
    J Exp Clin Cancer Res; 2017 Aug; 36(1):104. PubMed ID: 28774348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12/CXCR4 Axis Upregulates Twist to Induce EMT in Human Glioblastoma.
    Yao C; Li P; Song H; Song F; Qu Y; Ma X; Shi R; Wu J
    Mol Neurobiol; 2016 Aug; 53(6):3948-3953. PubMed ID: 26179613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells.
    Sui A; Xu Y; Li Y; Hu Q; Wang Z; Zhang H; Yang J; Guo X; Zhao W
    Oncotarget; 2017 Sep; 8(40):68591-68598. PubMed ID: 28978140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone H3 Lys 27 demethylase KDM6B promotes migration and invasion of glioma cells partly by regulating the expression of SNAI1.
    Sui A; Xu Y; Yang J; Pan B; Wu J; Guo T; Shen Y; Guo X
    Neurochem Int; 2019 Mar; 124():123-129. PubMed ID: 30633952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
    Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
    J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
    Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
    Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines.
    Wang H; Liu W; Wei D; Hu K; Wu X; Yao Y
    Oncol Lett; 2014 May; 7(5):1581-1585. PubMed ID: 24765180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells.
    Huang Z; Li G; Zhang Z; Gu R; Wang W; Lai X; Cui ZK; Zeng F; Xu S; Deng F
    BMC Cancer; 2019 Nov; 19(1):1142. PubMed ID: 31771535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
    Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
    Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis.
    Park WY; Hong BJ; Lee J; Choi C; Kim MY
    Cancer Res; 2016 Jan; 76(1):161-70. PubMed ID: 26729791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of altered CXCL12/CXCR4 axis on BMP2/Smad/Runx2/Osterix axis and osteogenic gene expressions during osteogenic differentiation of MSCs.
    Li Z; Wang W; Xu H; Ning Y; Fang W; Liao W; Zou J; Yang Y; Shao N
    Am J Transl Res; 2017; 9(4):1680-1693. PubMed ID: 28469774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro.
    Cives M; Quaresmini D; Rizzo FM; Felici C; D'Oronzo S; Simone V; Silvestris F
    Oncotarget; 2017 Apr; 8(14):22534-22549. PubMed ID: 28186979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity.
    Li F; Xu X; Geng J; Wan X; Dai H
    Exp Ther Med; 2020 Mar; 19(3):1844-1854. PubMed ID: 32104240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
    Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
    Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.